Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer
Thursday, July 16, 2020Novocure announced it has entered into a clinical trial collaboration agreement with MSD a tradename of Merck Co Inc through a subsidiary to develop Tumor Treating Fields together with MSDs antiPD therapy KEYTRUDA pembrolizumab for treatment of nons...
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
Thursday, July 16, 2020Orchard Therapeutics a global gene therapy leader today announced that the company has entered into two worldwide royaltybearing license agreements with GlaxoSmithKline plc GSK LSENYSE GSK for use of their proprietary lentiviral stable cell line tech...
Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development
Wednesday, July 15, 2020Sanofi and The University of Texas MD Anderson Cancer Center today announced a fiveyear strategic collaboration to accelerate the development of investigational treatments including targeted and immunetherapies for patients with cancer The alliance w...
Fate Therapeutics Announces Exclusive License Agreement with Baylor College of Medicine for Rejection-resistant iPSC-derived Cellular Therapies
Wednesday, July 15, 2020Fate Therapeutics Inc a clinicalstage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders today announced that the Company entered into an exclusive license agreement with Bayl...
Medicago begins Phase I clinical trials for candidate vaccine against COVID-19
Wednesday, July 15, 2020Medicago a biopharmaceutical company headquartered in Quebec City initiated Phase I clinical trials for the plantderived candidate vaccine against COVID during which the first doses were administered to healthy human volunteers Medicago also plans t...
Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101
Tuesday, July 14, 2020Ovid Therapeutics Inc a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases and Angelini Pharma SpA hereinafter Angelini Pharma an Italian familyowned pharmaceutical company c...
Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies
Tuesday, July 14, 2020Revitope Oncology Inc a biotechnology company advancing a new class of precision cancer immunotherapies its whollyowned subsidiary Revitope Limited Revitope Limited together with Revitope Oncology Revitope and Junshi Biosciences HK SH a leading inno...
Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients
Tuesday, July 14, 2020Merus NV a clinicalstage oncology company developing innovative fulllength multispecific antibodies Biclonics and Triclonics and Caris Life Sciences a leading innovator in molecular science focused on fulfilling the promise of precision medicine ann...
Samsung Biologics signs additional development and manufacturing agreement with STCube
Monday, July 13, 2020Samsung Biologics has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM an antiPD immunooncology candidate
Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived CAR T-Cell Therapy
Saturday, July 11, 2020Fate Therapeutics Inc a clinicalstage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders announced that the US Food and Drug Administration FDA has cleared the Companys Invest...
